These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 21154151)

  • 1. Dexpramipexole, the R(+) enantiomer of pramipexole, for the potential treatment of amyotrophic lateral sclerosis.
    Cheah BC; Kiernan MC
    IDrugs; 2010 Dec; 13(12):911-20. PubMed ID: 21154151
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety, tolerability, and pharmacokinetics of KNS-760704 (dexpramipexole) in healthy adult subjects.
    Bozik ME; Mather JL; Kramer WG; Gribkoff VK; Ingersoll EW
    J Clin Pharmacol; 2011 Aug; 51(8):1177-85. PubMed ID: 20959524
    [TBL] [Abstract][Full Text] [Related]  

  • 3. KNS-760704 [(6R)-4,5,6,7-tetrahydro-N6-propyl-2, 6-benzothiazole-diamine dihydrochloride monohydrate] for the treatment of amyotrophic lateral sclerosis.
    Gribkoff VK; Bozik ME
    CNS Neurosci Ther; 2008; 14(3):215-26. PubMed ID: 18801114
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical experience with pramipexole in the treatment of restless legs syndrome.
    Merlino G; Serafini A; Robiony F; Valente M; Gigli GL
    Expert Opin Drug Metab Toxicol; 2008 Feb; 4(2):225-35. PubMed ID: 18248314
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetic evaluation of pramipexole.
    Antonini A; Calandrella D
    Expert Opin Drug Metab Toxicol; 2011 Oct; 7(10):1307-14. PubMed ID: 21892895
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of dexpramipexole (KNS-760704) in individuals with amyotrophic lateral sclerosis.
    Cudkowicz M; Bozik ME; Ingersoll EW; Miller R; Mitsumoto H; Shefner J; Moore DH; Schoenfeld D; Mather JL; Archibald D; Sullivan M; Amburgey C; Moritz J; Gribkoff VK
    Nat Med; 2011 Nov; 17(12):1652-6. PubMed ID: 22101764
    [TBL] [Abstract][Full Text] [Related]  

  • 7. R+ pramipexole as a mitochondrially focused neuroprotectant: initial early phase studies in ALS.
    Wang H; Larriviere KS; Keller KE; Ware KA; Burns TM; Conaway MA; Lacomis D; Pattee GL; Phillips LH; Solenski NJ; Zivkovic SA; Bennett JP
    Amyotroph Lateral Scler; 2008 Feb; 9(1):50-8. PubMed ID: 18270879
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of pramipexole in REM sleep behavior disorder: results from a case series.
    Schmidt MH; Koshal VB; Schmidt HS
    Sleep Med; 2006 Aug; 7(5):418-23. PubMed ID: 16815751
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pramipexole: in restless legs syndrome.
    McCormack PL; Siddiqui MA
    CNS Drugs; 2007; 21(5):429-37; discussion 438-40. PubMed ID: 17447832
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of pramipexole in idiopathic restless legs syndrome: a polysomnographic dose-finding study--the PRELUDE study.
    Partinen M; Hirvonen K; Jama L; Alakuijala A; Hublin C; Tamminen I; Koester J; Reess J
    Sleep Med; 2006 Aug; 7(5):407-17. PubMed ID: 16815748
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeted antioxidative and neuroprotective properties of the dopamine agonist pramipexole and its nondopaminergic enantiomer SND919CL2x [(+)2-amino-4,5,6,7-tetrahydro-6-Lpropylamino-benzathiazole dihydrochloride].
    Danzeisen R; Schwalenstoecker B; Gillardon F; Buerger E; Krzykalla V; Klinder K; Schild L; Hengerer B; Ludolph AC; Dorner-Ciossek C; Kussmaul L
    J Pharmacol Exp Ther; 2006 Jan; 316(1):189-99. PubMed ID: 16188953
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potential neuroprotection mechanisms in PD: focus on dopamine agonist pramipexole.
    Albrecht S; Buerger E
    Curr Med Res Opin; 2009 Dec; 25(12):2977-87. PubMed ID: 19842998
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dopamine and cognitive functioning in de novo subjects with Parkinson's disease: effects of pramipexole and pergolide on working memory.
    Costa A; Peppe A; Dell'Agnello G; Caltagirone C; Carlesimo GA
    Neuropsychologia; 2009 Apr; 47(5):1374-81. PubMed ID: 19428401
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of the dopamine agonist pramipexole on depression, anhedonia and motor functioning in Parkinson's disease.
    Lemke MR; Brecht HM; Koester J; Reichmann H
    J Neurol Sci; 2006 Oct; 248(1-2):266-70. PubMed ID: 16814808
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacology of pramipexole, a dopamine D3-preferring agonist useful in treating Parkinson's disease.
    Piercey MF
    Clin Neuropharmacol; 1998; 21(3):141-51. PubMed ID: 9617505
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Meta-analysis of the efficacy and tolerability of pramipexole versus ropinirole in the treatment of restless legs syndrome.
    Quilici S; Abrams KR; Nicolas A; Martin M; Petit C; Lleu PL; Finnern HW
    Sleep Med; 2008 Oct; 9(7):715-26. PubMed ID: 18226947
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The long-term effects of the dopamine agonist pramipexole in a proposed restless legs syndrome animal model.
    Luo F; Li C; Ondo WG; Xu P; Xie W; Le W
    Sleep Med; 2011 Jan; 12(1):41-6. PubMed ID: 21044864
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chiral liquid chromatography-tandem mass spectrometry assay to determine that dexpramipexole is not converted to pramipexole in vivo after administered in humans.
    Wei D; Wu C; He P; Kerr D; Stecher S; Yang L
    J Chromatogr B Analyt Technol Biomed Life Sci; 2014 Nov; 971():133-40. PubMed ID: 25289790
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conversion from dopamine agonists to pramipexole. An open-label trial in 227 patients with advanced Parkinson's disease.
    Linazasoro G;
    J Neurol; 2004 Mar; 251(3):335-9. PubMed ID: 15015015
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pramipexole has astrocyte-mediated neuroprotective effects against lactacystin toxicity.
    Imamura K; Takeshima T; Nakaso K; Ito S; Nakashima K
    Neurosci Lett; 2008 Aug; 440(2):97-102. PubMed ID: 18555604
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.